奥精医疗
(688613)
| 流通市值：16.09亿 | | | 总市值：20.29亿 |
| 流通股本：1.07亿 | | | 总股本：1.36亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 178,413,682.11 | 161,251,900.09 | 167,992,280.22 | 202,341,280.14 |
| 应收票据及应收账款 | 76,259,788.13 | 59,270,254.21 | 46,107,309.75 | 44,752,327.33 |
| 应收账款 | 76,259,788.13 | 59,270,254.21 | 46,107,309.75 | 44,752,327.33 |
| 预付款项 | 5,037,470.89 | 7,680,661.12 | 5,708,328.61 | 9,285,490.84 |
| 其他应收款合计 | 2,271,890.3 | 6,400,321.13 | 10,599,146.53 | 6,047,579.41 |
| 存货 | 27,672,219.39 | 32,704,015.74 | 35,372,018.03 | 28,964,100.16 |
| 其他流动资产 | 4,338,004.11 | 31,261,921.79 | 1,590,473.4 | 3,789,126.6 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,200,374,680.67 | 1,200,748,124.98 | 1,177,874,828.66 | 1,176,306,210.46 |
| 非流动资产: | | | | |
| 投资性房地产 | 54,858,761.72 | 55,597,991.87 | 56,337,180.52 | 57,076,348.42 |
| 固定资产 | 180,211,266.56 | 182,427,784.25 | 164,879,037.62 | 162,365,509.6 |
| 在建工程 | 332,868.07 | 332,868.07 | 18,676,955.74 | 17,682,760.81 |
| 使用权资产 | 3,390,115.35 | 3,806,530.5 | 19,321,450.95 | 19,892,579.76 |
| 无形资产 | 21,738,583.26 | 22,062,398.79 | 22,386,214.32 | 22,710,029.85 |
| 开发支出 | - | - | 1,946.9 | - |
| 长期待摊费用 | 33,966,835 | 34,656,067.96 | 19,267,505.42 | 20,080,062.73 |
| 递延所得税资产 | 21,733,836.44 | 21,733,836.44 | 18,591,168.84 | 18,591,168.84 |
| 其他非流动资产 | 3,930,628.57 | 4,891,250.57 | 4,219,148.57 | 4,092,408.57 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 320,162,894.97 | 325,508,728.45 | 323,680,608.88 | 322,490,868.58 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,520,537,575.64 | 1,526,256,853.43 | 1,501,555,437.54 | 1,498,797,079.04 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 5,840,988.74 | 10,387,177.69 | 12,328,153.44 | 15,182,678.03 |
| 应付账款 | 5,840,988.74 | 10,387,177.69 | 12,328,153.44 | 15,182,678.03 |
| 合同负债 | 8,582,925.09 | 10,231,987.68 | 2,655,060.49 | 6,973,261.46 |
| 应付职工薪酬 | 3,974,251.65 | 11,336,135.29 | 4,096,349.74 | 3,381,133.72 |
| 应交税费 | 3,081,377.11 | 1,893,048.03 | -464,161.45 | 943,246.82 |
| 其他应付款合计 | 7,353,673.46 | 11,567,810.75 | 7,097,962.69 | 7,319,303.43 |
| 一年内到期的非流动负债 | 3,567,985.2 | 5,067,985.2 | 3,600,000 | 6,393,235.02 |
| 其他流动负债 | 257,487.76 | 306,959.62 | 79,651.81 | 209,197.84 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 32,658,689.01 | 50,791,104.26 | 29,393,016.72 | 40,402,056.32 |
| 非流动负债: | | | | |
| 长期借款 | 45,552,173.33 | 45,352,173.33 | 46,352,173.33 | 47,652,173.33 |
| 租赁负债 | 2,822,092.44 | 2,996,525.33 | - | - |
| 递延收益 | 22,351,742.25 | 22,191,742.25 | 34,941,981.25 | 34,941,981.25 |
| 递延所得税负债 | 1,280,048.68 | 1,280,048.68 | 4,199,911.76 | 4,199,911.76 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 72,006,056.7 | 71,820,489.59 | 85,494,066.34 | 86,794,066.34 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 104,664,745.71 | 122,611,593.85 | 114,887,083.06 | 127,196,122.66 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 133,333,334 | 133,333,334 | 133,333,334 | 133,333,334 |
| 资本公积 | 934,135,434.04 | 926,924,889.61 | 911,176,424.49 | 899,873,224.49 |
| 其他综合收益 | - | - | 228,313.54 | 228,313.54 |
| 盈余公积 | 45,832,496.59 | 45,832,496.59 | 42,384,508.99 | 42,384,508.99 |
| 未分配利润 | 282,927,038.44 | 275,988,930.99 | 278,963,318.76 | 274,663,508.65 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,396,228,303.07 | 1,382,079,651.19 | 1,366,085,899.78 | 1,350,482,889.67 |
| 少数股东权益 | 19,644,526.86 | 21,565,608.39 | 20,582,454.7 | 21,118,066.71 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,415,872,829.93 | 1,403,645,259.58 | 1,386,668,354.48 | 1,371,600,956.38 |
| 负债和股东权益合计 | 1,520,537,575.64 | 1,526,256,853.43 | 1,501,555,437.54 | 1,498,797,079.04 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-27 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |